CC
ELV icon

Copperleaf Capital’s Elevance Health ELV Stock Holding History

Copperleaf Capital’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-3,962
Closed -$1.54M – 119
2025
Q2 		$1.54M Buy
3,962
+90
+2% +$36.2K 0.78% 35
2025
Q1 		$1.68M Buy
3,872
+1,633
+73% +$656K 1.01% 27
2024
Q4 		$826K Sell
2,239
-485
-18% -$203K 0.52% 53
2024
Q3 		$1.42M Sell
2,724
-49
-2% -$26.2K 1.08% 30
2024
Q2 		$1.5M Buy
2,773
+151
+6% +$79.8K 1.2% 28
2024
Q1 		$1.36M Buy
2,622
+111
+4% +$55.2K 1.18% 28
2023
Q4 		$1.18M Sell
2,511
-85
-3% -$39.3K 1.21% 27
2023
Q3 		$1.13M Sell
2,596
-35
-1% -$15.9K 1.22% 25
2023
Q2 		$1.17M Sell
2,631
-606
-19% -$280K 1.1% 29
2023
Q1 		$1.49M Sell
3,237
-19
-0.6% -$9.04K 1.48% 22
2022
Q4 		$1.67M Buy
3,256
+81
+3% +$41.1K 1.92% 17
2022
Q3 		$1.44M Buy
3,175
+182
+6% +$87.1K 1.56% 18
2022
Q2 		$1.44M Buy
2,993
+53
+2% +$26.2K 1.46% 24
2022
Q1 		$1.44M Buy
2,940
+31
+1% +$14.2K 1.28% 27
2021
Q4 		$1.35M Sell
2,909
-298
-9% -$125K 1.16% 28
2021
Q3 		$1.2M Buy
3,207
+66
+2% +$25.1K 1.15% 31
2021
Q2 		$1.2M Sell
3,141
-82
-3% -$31.3K 1.17% 29
2021
Q1 		$1.16M Buy
3,223
+181
+6% +$58.2K 1.23% 26
2020
Q4 		$977K Sell
3,042
-303
-9% -$93K 0.83% 37
2020
Q3 		$898K Sell
3,345
-28
-0.8% -$7.53K 0.86% 39
2020
Q2 		$887K Sell
3,373
-104
-3% -$27.7K 0.92% 36
2020
Q1 		$789K Sell
3,477
-406
-10% -$111K 0.95% 31
2019
Q4 		$1.17M Buy
+3,883
New +$1.07M 1.19% 27

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Copperleaf Capital's ELV Position: Q3 2025 in Review

Copperleaf Capital sold out of Elevance Health (ELV) in Q3 2025, closing a stake of 3,962 shares — an estimated $1.54M sold.

Copperleaf Capital first reported a position in ELV in Q4 2019 and held it in 23 quarters. The position peaked at $1.68M in Q1 2025. 1,510 funds tracked by Wall St. Rank hold ELV as of Q3 2025.

  • Copperleaf Capital reported no remaining Elevance Health position as of Q3 2025 after selling out during the quarter.
  • Copperleaf Capital sold 3,962 Elevance Health shares in Q3 2025, an estimated $1.54M.
  • Copperleaf Capital first reported a position in Elevance Health in Q4 2019 and held it in 23 quarters.
  • Copperleaf Capital's Elevance Health position peaked at $1.68M in Q1 2025.
  • 1,510 funds tracked by Wall St. Rank held Elevance Health as of Q3 2025.

Based on Copperleaf Capital's 13F filing for Q3 2025, filed 28 Oct 2025.